Finstad Alexandra, Lee Alex, George Ralph, Alhusayen Raed
Faculty of Medicine, University of Ottawa, Ottawa, ON, Canada.
Division of General Surgery, Department of Surgery, University of Toronto, Toronto, ON, Canada.
JMIR Dermatol. 2021 Dec 14;4(2):e31047. doi: 10.2196/31047.
Hidradenitis suppurativa (HS) is a painful inflammatory disorder that confers significant distress to patients, with surgery as an integral treatment modality.
To inform improvements in care, patterns in HS surgery were assessed.
A retrospective population-based analysis was performed on Ontario billing claims for HS surgery across a period of 10 years from January 1, 2008 to December 31, 2017. HS surgery was defined as the excision of inguinal, perineal, or axillary skin and sweat glands for hidradenitis. The top 5 billing specialties, including general and plastic surgery, were analyzed. The total number of procedures performed as well as the number performed per physician were investigated. Patient and physician locations were compared.
A total of 7195 claims for the excision of inguinal, perineal, or axillary skin and sweat glands for HS were submitted across the study period. Annual HS surgery claims showed an increasing trend across 10 years, ranging between 4.9 and 5.8 per 100,000 population. However, overall, for every additional year, the number of claims per 100,000 population only increased slightly, by 0.03 claims. The number of providers steadily decreased, ranging between 1.7 and 1.9 per 100,000, with approximately twice as many general than plastic surgeons. However, again overall, for every additional year, the number of providers per 100,000 population decreased slightly, by 0.002 physicians. The mean annual number of procedures per physician rose from 2.8 to 3.1. In rural areas, analyzed per claim, general surgeons performed the majority of surgeries (1318/2003, 65.8%), while in urban areas, surgeries were more equally performed by general (2616/5192, 50.4%) and plastic (2495/5192, 48.1%) surgeons. Of HS surgery claims, 25.7%-35.9% were provided by a physician residing in a different area than the patient receiving care.
No significant improvements in access to HS surgery were seen across the study period, with access potentially worsening with annual HS claims rising overall and number of providers decreasing, with patients travelling further to access surgery. System barriers across the continuum of HS diagnosis and management must be evaluated to improve access to surgical care.
化脓性汗腺炎(HS)是一种疼痛性炎症性疾病,给患者带来极大痛苦,手术是其重要的治疗方式。
评估HS手术模式,以促进护理改善。
对2008年1月1日至2017年12月31日这10年间安大略省HS手术的计费索赔进行基于人群的回顾性分析。HS手术定义为因化脓性汗腺炎切除腹股沟、会阴或腋窝皮肤及汗腺。分析了包括普通外科和整形外科在内的前5个计费专业。调查了手术总例数以及每位医生的手术例数。比较了患者和医生的所在地。
在研究期间,共提交了7195例因HS切除腹股沟、会阴或腋窝皮肤及汗腺的索赔。HS手术年度索赔在10年间呈上升趋势,每10万人中的索赔数在4.9至5.8之间。然而,总体而言,每增加一年,每10万人中的索赔数仅略有增加,增加0.03例。医疗服务提供者数量稳步下降,每10万人中在1.7至1.9之间,普通外科医生的数量约为整形外科医生的两倍。然而,总体而言,每增加一年,每10万人中的医疗服务提供者数量略有下降,减少0.002名医生。每位医生的年均手术例数从2.8增至3.1。在农村地区,按索赔分析,普通外科医生进行了大部分手术(1318/2003,65.8%),而在城市地区,普通外科医生(2616/5192,50.4%)和整形外科医生(2495/5192,48.1%)进行手术的比例更为均衡。在HS手术索赔中,25.7%-35.9%是由居住在与接受治疗患者不同地区的医生提供的。
在研究期间,HS手术的可及性未见显著改善,随着HS年度索赔总体上升和医疗服务提供者数量减少,可及性可能变差,患者需前往更远的地方接受手术。必须评估HS诊断和管理全过程中的系统障碍,以改善手术护理的可及性。